Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs-Reference-Cited by-同舟云学术

Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs

Published:2017-10-18 Issue:21 Volume:60 Page:9012-9021
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Artigas Gerard¹,Monteiro João T.²,Hinou Hiroshi¹³,Nishimura Shin-Ichiro¹³^ORCID,Lepenies Bernd²,Garcia-Martin Fayna¹^ORCID

Affiliation:

1. Faculty of Advanced Life Science and Graduate School of Life Science, Hokkaido University, N21, W11, Kita-ku, 001-0021 Sapporo, Japan

2. Immunology Unit & Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Bünteweg 17, 30559 Hannover, Germany

3. Medicinal Chemistry Pharmaceuticals, Co., Ltd. N9W15, Chuo-ku, 060-0009 Sapporo, Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Deutsche Forschungsgemeinschaft

Japan Society for the Promotion of Science

Canon Foundation in Europe

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01242

Reference58 articles.

1. Glycobiology of immune responses

2. Glycosylation in cancer: mechanisms and clinical implications

3. C-type lectins: their network and roles in pathogen recognition and immunity

4. The C-type lectin superfamily in the immune system

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Thermodynamic Evaluation of Sialyl‐Tn MUC1 Glycopeptides Binding to Macrophage Galactose‐Type Lectin;ChemBioChem;2024-07-30

2. The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment;Expert Opinion on Therapeutic Targets;2024-07-02

3. Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy;ACS Nano;2024-03-27

4. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design;Frontiers in Immunology;2023-11-27

5. Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors;Molecular Pharmaceutics;2023-09-18